Research Paper

E2F-1 lacking the transcriptional activity domain induces autophagy

Volume 13, Issue 11   September 2012
Pages 1091 - 1101
http://dx.doi.org/10.4161/cbt.21143
Keywords: E2F-1, E2Ftr, adenovirus, apoptosis, autophagy, melanoma
Authors: Aracely Garcia-Garcia, Humberto Rodriguez-Rocha, Michael T. Tseng, Roberto Montes de Oca-Luna, H. Sam Zhou, Kelly M. McMasters and Jorge G. Gomez-Gutierrez

View affiliations

Abstract:
The transcription factor E2F-1 plays a crucial role in the control of cell proliferation. E2F-1 has tumor suppressive properties by inducing apoptosis and autophagy. In this study, E2F-1 and its truncated form (E2Ftr), lacking the transactivation domain (TAD), were compared for their ability to induce autophagy. In Gaussia luciferase-based assays, both E2F-1 and E2Ftr induced the proteolytic cleavage of the autophagic marker LC3. In addition, LC3 and autophagy protein 5 (Atg5) were upregulated by E2F-1 and E2Ftr. Likewise, both E2F proteins induced a punctate pattern of GFP-tagged LC3, indicating autophagosome formation. The presence of double-membrane autophagic vesicles induced by E2F-1 and E2Ftr was confirmed by transmission electron microscopy (TEM). The application of z-VAD-fmk, a caspase inhibitor, partially blocked both E2F-1 and E2Ftr-mediated cytotoxicity. Moreover, Atg5−/− cells were more resistant to the E2F-1 or E2Ftr-induced cell killing effect than Atg5 wt cells. The TAD of E2F-1 is not essential for induction of autophagy; apoptosis and autophagy cooperate for an efficient cancer cell killing effect induced by E2F-1 or E2Ftr. E2Ftr-induced autophagy is a promising approach to destroy tumors that are resistant to conventional treatments.

Received: April 3, 2012; Accepted: June 17, 2012; Published Online: July 24, 2012

Preview:



Full Text Available - Log in!  


Comments

Please Log In to comment on this article.
If you do not have an account Create One Here.

blog comments powered by Disqus

Advertisements